ARS Pharmaceuticals Inc.
SPRY | NASDAQ
$4.42
+$0.07 (+1.61%)
Sep 22, 2026, 1:40 PM ET · Market open
Fiscal Quarter Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 33.66M | 22.68M | 28.09M | 32.5M | 15.72M | 7.97M | 86.58M | 2.07M | 500K | n/a | n/a | n/a | 10K | 20K | n/a | 189K | 464K | 663K | 754K | 528K | 2.11M | 2.11M |
Cost of Revenue | 12.85M | 6.29M | 3.2M | 8.19M | 4.98M | 4.05M | 3.89M | 112K | 6.9M | 5.23M | 3.4M | 3M | 7.21M | 6.45M | 3.55M | 3.79M | 4.35M | 5.42M | 3.91M | 5.12M | 5.62M | 5.62M |
Gross Profit | 20.81M | 16.4M | 24.89M | 24.31M | 10.73M | 3.93M | 82.69M | 1.96M | -6.4M | -5.23M | -3.4M | -3M | -7.2M | -6.43M | -3.55M | -3.6M | -3.89M | -4.76M | -3.16M | -4.59M | -3.51M | -3.51M |
Operating Income | -61.47M | -60.15M | -41.47M | -53.19M | -47.61M | -37.18M | 47.2M | -21.75M | -15.34M | -13.19M | -10.23M | -17.98M | -20.6M | -18.71M | -15.44M | -6.63M | -6.34M | -7.1M | -4.96M | -5.62M | -4.44M | -4.44M |
Interest Income | 1.61M | 1.97M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 47K | n/a | n/a | n/a |
Pretax Income | -62.34M | -60.62M | -41.4M | -51.15M | -44.88M | -33.94M | 50.22M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M | -4.65M | -4.65M |
Net Income | -62.34M | -60.62M | -41.32M | -51.15M | -44.88M | -33.94M | 49.93M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M | -4.65M | -4.65M |
Selling & General & Admin | 77.58M | 72.2M | 59.96M | 74.75M | 54.31M | n/a | n/a | 19.28M | 8.94M | n/a | n/a | n/a | 13.41M | 12.28M | 10.83M | 3.03M | 2.46M | 2.34M | 1.8M | 1.02M | 932K | 932K |
Research & Development | 4.7M | 4.34M | 3.44M | 2.75M | 4.04M | 2.95M | 3.03M | 4.42M | 6.9M | 5.23M | 3.4M | 3M | 7.31M | 6.55M | 4.71M | 3.89M | 4.35M | 5.42M | 3.91M | 5.12M | 5.62M | 5.62M |
Other Expenses | n/a | n/a | 2.95M | n/a | n/a | 38.15M | 32.47M | n/a | -6.9M | 2.72M | 3.42M | 11.97M | -7.31M | -6.55M | -3.65M | -3.89M | -4.35M | -5.42M | -3.91M | -5.12M | -5.62M | -5.62M |
Operating Expenses | 82.28M | 76.54M | 66.35M | 77.5M | 58.35M | 41.1M | 35.49M | 23.7M | 8.94M | 7.96M | 6.82M | 14.98M | 13.41M | 12.28M | 11.89M | 3.03M | 2.46M | 2.34M | 1.8M | 1.02M | 932K | 932K |
Interest Expense | 2.48M | 2.44M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 100K | 100K | 100K | 100K | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 95.12M | 82.83M | 69.55M | 85.69M | 63.33M | 45.15M | 39.38M | 23.82M | 15.84M | 13.19M | 10.23M | 17.98M | 20.61M | 18.73M | 15.44M | 6.82M | 6.81M | 7.76M | 5.72M | 6.14M | 6.55M | 6.55M |
Income Tax Expense | n/a | n/a | -80K | n/a | n/a | n/a | 288K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
Shares Outstanding (Diluted) | 99.31M | 99.3M | 98.57M | 98.81M | 98.36M | 98.06M | 97.95M | 97.03M | 96.83M | 96.49M | 96.13M | 95.58M | 94.91M | 94.23M | 94M | 93.77M | 93.77M | 93.77M | 35.04M | 35M | 34.88M | 34.77M |
EPS (Basic) | -0.63 | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.16 | -0.15 | -0.07 | -0.07 | -0.08 | -0.15 | -0.17 | -0.13 | -0.13 |
EPS (Diluted) | -0.63 | -0.61 | -0.42 | -0.52 | -0.46 | -0.35 | 0.51 | -0.20 | -0.13 | -0.11 | -0.07 | -0.16 | -0.18 | -0.16 | -0.15 | -0.07 | -0.07 | -0.08 | -0.15 | -0.17 | -0.13 | -0.13 |
EBITDA | -61.47M | -57.78M | -40.99M | -48.8M | -44.6M | -33.66M | 50.25M | -19.11M | -12.5M | -10.28M | -7.16M | -14.85M | -17.35M | -14.94M | -14.17M | -6.58M | -6.41M | -7.2M | -4.93M | -5.81M | -4.65M | -4.44M |
EBIT | -61.47M | -58.18M | -41.4M | -51.15M | -44.88M | -33.94M | 50.22M | -19.13M | -12.52M | -10.29M | -7.17M | -14.87M | -17.37M | -14.96M | -14.43M | -6.58M | -6.42M | -7.25M | -5.14M | -5.81M | -4.65M | -4.44M |
Depreciation & Amortization | n/a | 397K | 417K | 2.35M | 279K | 280K | 29K | 21K | 18K | 11K | 12K | 21K | 20K | 20K | 255.5K | 7K | 6.5K | 50K | 208K | 2K | 1.5K | 1.5K |
Add to Watchlist
Select watchlists to add or remove SPRY